IN BRIEF: Syncona investee Achilles Therapeutics files for US IPO Read More
IN BRIEF: Syncona's Gyroscope Reports Positive Results From GT005 Test Read More
Syncona Net Asset Value Dips In Third Quarter, Invests More In Quell Read More
Syncona Investee Autolus Nets USD100 Million From ADS Offer Read More
Syncona Investee Freeline Modifies Hemophilia Plan After FDA Feedback Read More
Syncona Investee Achilles Reports Positive Trial Review, Mulling IPO Read More
Syncona Investee Autolus To Focus On Adult Leukemia Programme in 2021 Read More
UK EXECUTIVE CHANGE SUMMARY: Ferguson Taps Former Ashtead, Bunzl Execs Read More
Syncona Portfolio Companies Boost Interim Result; Launches New Company Read More
UK Earnings, Trading Statements Calendar - Next 7 Days Read More
UK EXECUTIVE CHANGE SUMMARY: Kakuzi Acts To Prevent Human Rights Abuse Read More
Syncona Investee Freeline Posts Widened Interim Loss On Higher Costs Read More
UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation Read More
Syncona Life Science Portfolio Boosted By Autolus And Freeline Read More
Syncona Investee Freeline Therapeutics Prices IPO In New York Read More
UK TRADING UPDATE SUMMARY: Bluebird To Buy Southern Gold Venture Stake Read More
Syncona Investee Freeline Therapeutics Files For Possible US Listing Read More
Syncona's Investee Freeline Publishes Further Data For FLT180a Read More
Syncona Investee Freeline Raises USD120 Million And Mulls US Listing Read More
DIRECTOR DEALINGS: Syncona Non-Exec Reverberi Buys GBP50,000 In Shares Read More
